Your browser doesn't support javascript.
loading
Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.
Koyama, S; Fujisawa, S; Watanabe, R; Itabashi, M; Ishibashi, D; Ishii, Y; Hattori, Y; Nakajima, Y; Motohashi, K; Takasaki, H; Kawasaki, R; Hashimoto, C; Yamazaki, E; Koharazawa, H; Takemura, S; Tomita, N; Sakai, R; Motomura, S; Nakajima, H.
Afiliação
  • Koyama S; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Watanabe R; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Itabashi M; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Ishibashi D; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.
  • Ishii Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hattori Y; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Nakajima Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Motohashi K; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Takasaki H; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Kawasaki R; Department of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan.
  • Hashimoto C; Department of Hematology, Yamato Municipal Hospital, Yamato, Japan.
  • Yamazaki E; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Koharazawa H; Department of Hematology, Yamato Municipal Hospital, Yamato, Japan.
  • Takemura S; Department of Internal Medicine, Yokohama Ekisaikai Hospital, Yokohama, Japan.
  • Tomita N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sakai R; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Motomura S; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Int J Lab Hematol ; 39(1): 112-117, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27885817

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Ferritinas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Ferritinas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article